Royal Bank of Canada
TFFP

Royal Bank of Canada’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

Royal Bank of Canada’s Portfolio TFFP Stock Details TFFP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-156
Closed – – 7641
2024
Q2 		$0 Sell
156
-331
-68% -$868 ﹤0.01% 7670
2024
Q1 		$3K Buy
487
+178
+58% +$1.17K ﹤0.01% 6636
2023
Q4 		$2K Buy
+309
New +$2.4K ﹤0.01% 6857
2023
Q3 		– Sell
-5
Closed – – 7729
2023
Q2 		$0 Buy
+5
New +$72 ﹤0.01% 7757
2022
Q4 		– Sell
-25
Closed -$2K – 7853
2022
Q3 		$2K Buy
25
+5
+25% +$676 ﹤0.01% 7088
2022
Q2 		$3K Hold
20
– – ﹤0.01% 6876
2022
Q1 		$3K Sell
20
-1
-5% -$162 ﹤0.01% 7417
2021
Q4 		$4K Buy
21
+1
+5% +$194 ﹤0.01% 7296
2021
Q3 		$4K Buy
+20
New +$4.25K ﹤0.01% 7217
2021
Q2 		– Sell
-194
Closed -$66K – 7749
2021
Q1 		$66K Sell
194
-3
-2% -$1.22K ﹤0.01% 5719
2020
Q4 		$71K Buy
197
+3
+2% +$1.16K ﹤0.01% 5506
2020
Q3 		$90K Buy
+194
New +$54.8K ﹤0.01% 5036
2020
Q2 		– Sell
-200
Closed -$19K – 6975
2020
Q1 		$19K Buy
200
+120
+150% +$14.3K ﹤0.01% 5579
2019
Q4 		$11K Buy
+80
New +$10.3K ﹤0.01% 6120

Other funds holding TFFP

CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $2B AUM 34.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada's TFFP Position: Q3 2024 in Review

Royal Bank of Canada sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q3 2024, closing a stake of 156 shares.

Royal Bank of Canada first reported a position in TFFP in Q4 2019 and held it in 14 quarters. The position peaked at $90K in Q3 2020. 23 funds tracked by Wall St. Rank hold TFFP as of Q3 2024.

  • Royal Bank of Canada reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Royal Bank of Canada sold 156 TFF Pharmaceuticals, Inc. Common Stock shares in Q3 2024.
  • Royal Bank of Canada first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2019 and held it in 14 quarters.
  • Royal Bank of Canada's TFF Pharmaceuticals, Inc. Common Stock position peaked at $90K in Q3 2020.
  • 23 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q3 2024.

Based on Royal Bank of Canada's 13F filing for Q3 2024, filed 14 Nov 2024.